Policy in focus: Is psilocybin the next cannabis?

CMAJ. 2021 Nov 15;193(45):E1741-E1742. doi: 10.1503/cmaj.1095974.
No abstract available

Publication types

  • News

MeSH terms

  • Canada
  • Combined Modality Therapy
  • Hallucinogens / therapeutic use*
  • Health Policy*
  • Humans
  • Medical Marijuana / therapeutic use*
  • Mental Disorders / drug therapy*
  • Mental Disorders / therapy
  • Psilocybin / therapeutic use*
  • Psychotherapy / methods
  • United States

Substances

  • Hallucinogens
  • Medical Marijuana
  • Psilocybin